Leading drugmaker Sun Pharma is doubling down on its specialty portfolio, launching new products and ramping up ...

Revenue climbed 8.6% to Rs 14,405.2 crore, driven by double-digit growth in India, emerging markets, and rest of world (RoW) ...

So, if you're able to regularly invest in the Vanguard fund for many years, history offers us reason to be optimistic about ...

Investors seeking momentum may have iShares U.S. Pharmaceuticals ETF IHE on radar now. The fund recently hit a new 52-week high. Shares of IHE are up approximately 29.6% from their 52-week low of $58.